Cardio Diagnostics Begins In-House Test Processing at Its New High Complexity CLIA-Certified Laboratory in Iowa City
Cardio Diagnostics launched its in-house, high complexity CLIA-certified laboratory in Iowa City, assuming end-to-end control of its multi-omics clinical tests. This vertical integration replaces previous third-party arrangements and is expected to improve unit economics, supporting gross margins of approximately 40% at scale.
Key figures
- Gross margin target
- 40%
- Turnaround time days
- 7-10
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.